OpenURL Connection Search

Select item for more details and to access through your institution.

Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre--positron emission tomography era: A Gruppo Italiano Studio Linfomi (GISL) prospective trial.
Published in:
2009
By:
- Iannitto E;
- Minardi V;
- Gobbi PG;
- Calvaruso G;
- Tripodo C;
- Marcheselli L;
- Luminari S;
- Merli F;
- Baldini L;
- Stelitano C;
- Callea V;
- Petrini M;
- Angrilli F;
- Quarta G;
- Vallisa D;
- Molica S;
- Liardo E;
- Polimeno G;
- Brugiatelli M;
- Federico M
Publication type:
Journal Article
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Published in:
2011
By:
- Di Renzo N;
- Montanini A;
- Mannina D;
- Dondi A;
- Muci S;
- Mancuso S;
- De Paolis MR;
- Plati C;
- Stelitano C;
- Patti C;
- Olivieri A;
- Liardo E;
- Buda G;
- Cantaffa R;
- Federico M;
- Di Renzo, Nicola;
- Montanini, Antonella;
- Mannina, Donato;
- Dondi, Alessandra;
- Muci, Stefania
Publication type:
journal article
The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Published in:
Bone Marrow Transplantation, 2006, v. 37, n. 3, p. 283, doi. 10.1038/sj.bmt.1705235
By:
- Morabito, F.;
- Stelitano, C.;
- Luminari, S.;
- Mammi, C.;
- Marcheselli, L.;
- Callea, V.;
- Gentile, M.;
- Polimeno, G.;
- Merli, F.;
- Molica, S.;
- Gobbi, P.;
- Angrilli, F.;
- Brugiatelli, M.;
- Federico, M.
Publication type:
Article
Treatment of chronic lymphocytic leukemia in early and stable phase of the disease: Long-term results of a randomized trial.
Published in:
European Journal of Haematology, 1995, v. 55, n. 3, p. 158, doi. 10.1111/j.1600-0609.1995.tb00244.x
By:
- Brugiatelli, M.;
- Jaksic, B.;
- Planinc-Peraica, A.;
- Kusec, R.;
- Ostojic, S.;
- Callea, V.;
- Lacopino, P.;
- Morabito, F.;
- Stelitano, C.;
- Lutz, D.
Publication type:
Article
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays.
Published in:
Leukemia (08876924), 2012, v. 26, n. 3, p. 499, doi. 10.1038/leu.2011.247
By:
- Ciccone, M;
- Agostinelli, C;
- Rigolin, G M;
- Piccaluga, P P;
- Cavazzini, F;
- Righi, S;
- Sista, M T;
- Sofritti, O;
- Rizzotto, L;
- Sabattini, E;
- Fioritoni, G;
- Falorio, S;
- Stelitano, C;
- Olivieri, A;
- Attolico, I;
- Brugiatelli, M;
- Zinzani, P L;
- Saccenti, E;
- Capello, D;
- Negrini, M
Publication type:
Article
Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial.
Published in:
Leukemia (08876924), 2006, v. 20, n. 10, p. 1840, doi. 10.1038/sj.leu.2404346
By:
- Ladetto, M.;
- Vallet, S.;
- Benedetti, F.;
- Vitolo, U.;
- Martelli, M.;
- Callea, V.;
- Patti, C.;
- Coser, P.;
- Perrotti, A.;
- Sorio, M.;
- Boccomini, C.;
- Pulsoni, A.;
- Stelitano, C.;
- Scimè, R.;
- Boccadoro, M.;
- Rosato, R.;
- De Marco, F.;
- Zanni, M.;
- Corradini, P.;
- Tarella, C.
Publication type:
Article
Lipid peroxidation and protein oxidation in patients affected by Hodgkin's lymphoma.
Published in:
Mediators of Inflammation, 2004, v. 13, n. 5/6, p. 381, doi. 10.1080/09629350400008760
By:
- Morabito, F.;
- Cristani, M.;
- Saija, A.;
- Stelitano, C.;
- Callea, V.;
- Tomaino, A.;
- Minciullo, P. L.;
- Gangemi, S.
Publication type:
Article
A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS WITH COMPLETE METABOLIC RESPONSE AFTER STANDARD IMMUNOCHEMOTHERAPY.
Published in:
Hematological Oncology, 2023, v. 41, p. 48, doi. 10.1002/hon.3163_19
By:
- Davies, A. J.;
- Zucca, E.;
- Ceriani, L.;
- Kryachok, I.;
- Ciccone, G.;
- Botto, B.;
- Balzarotti, M.;
- Tucci, A.;
- Rusconi, C.;
- Usai, S. V.;
- Pennese, E.;
- Arcaini, L.;
- Dabrowska‐Iwanicka, A.;
- Ferreri, A. J. M.;
- Merli, F.;
- Zhao, W.;
- Hodgson, D.;
- Rigacci, L.;
- Cellini, C.;
- Stelitano, C.
Publication type:
Article
A COMPLETELY GENETIC PROGNOSTIC MODEL OVERCOMES CLINICAL PROGNOSTICATORS IN MANTLE CELL LYMPHOMA: RESULTS FROM THE MCL0208 TRIAL FROM THE FONDAZIONE ITALIANA LINFOMI (FIL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.59_2879
By:
- Ferrero, S.;
- Moia, R.;
- Cascione, L.;
- Zaccaria, G. M.;
- Rinaldi, A.;
- Alessandria, B.;
- Grimaldi, D.;
- Favini, C.;
- Evangelista, A.;
- Schipani, M.;
- Narni, F.;
- Stelitano, C.;
- Stefani, P. M.;
- Benedetti, F.;
- Mian, M.;
- Casaroli, I.;
- Zanni, M.;
- Castellino, C.;
- Pavone, V.;
- Galimberti, S.
Publication type:
Article
UPDATED RESULTS OF THE FIL “MIRO” STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.31_2880
By:
- Pulsoni, A.;
- Tosti, M. E.;
- Ferrero, S.;
- Luminari, S.;
- Dondi, A.;
- Liberati, A. M.;
- Cenfra, N.;
- Renzi, D.;
- Zanni, M.;
- Boccomini, C.;
- Ferreri, A. J.;
- Rattotti, S.;
- Zilioli, V. R.;
- Bernuzzi, P.;
- Bolis, S.;
- Musuraca, G.;
- Nassi, L.;
- Perrone, T.;
- Stelitano, C.;
- Anastasia, A.
Publication type:
Article
UPDATED RESULTS OF THE FIL “MIRO” STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.30_2880
By:
- Pulsoni, A.;
- Tosti, M. E.;
- Ferrero, S.;
- Luminari, S.;
- Dondi, A.;
- Liberati, A. M.;
- Cenfra, N.;
- Renzi, D.;
- Zanni, M.;
- Boccomini, C.;
- Ferreri, A. J.;
- Rattotti, S.;
- Zilioli, V. R.;
- Bernuzzi, P.;
- Bolis, S.;
- Musuraca, G.;
- Nassi, L.;
- Perrone, T.;
- Stelitano, C.;
- Anastasia, A.
Publication type:
Article
ANAPLASTIC LARGE CELL LYMPHOMA, ALK‐NEGATIVE: ANALYSIS OF 235 CASES COLLECTED BY THE T‐CELL PROJECT.
Published in:
Hematological Oncology, 2019, v. 37, p. 283, doi. 10.1002/hon.93_2630
By:
- Shustov, A.;
- Cabrera, M.;
- Bellei, M.;
- Civallero, M.;
- Ko, Y.H.;
- Manni, M.;
- Horwitz, S.M.;
- Antonio De Souza, C.;
- Radford, J.;
- Varela, S.B.;
- Prates, M.V.;
- Ferreri, A.;
- Chiattone, C.;
- Spina, M.;
- Vose, J.M.;
- Chiappella, A.;
- Laszlo, D.;
- Marino, D.;
- Stelitano, C.;
- Skrypets, T.
Publication type:
Article
LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT).
Published in:
Hematological Oncology, 2019, v. 37, p. 256, doi. 10.1002/hon.65_2630
By:
- Ferreri, A.J.;
- Sassone, M.C.;
- Angelillo, P.;
- Zaja, F.;
- Re, A.;
- Spina, M.;
- Di Rocco, A.;
- Fabbri, A.;
- Stelitano, C.;
- Frezzato, M.;
- Rusconi, C.;
- Zambello, R.;
- Arcari, A.;
- Bertoldero, G.;
- De Lorenzo, D.;
- Volpetti, S.;
- Calimeri, T.;
- Perrone, S.;
- Cecchetti, C.;
- Ciceri, F.
Publication type:
Article
FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 224, doi. 10.1002/hon.39_2630
By:
- Ferrero, S.;
- Ladetto, M.;
- Beldjord, K.;
- Drandi, D.;
- Stelitano, C.;
- Bernard, S.;
- Castagnari, B.;
- Bouabdallah, K.;
- Cesaretti, M.;
- Alvarez, I.;
- Gressin, R.;
- Ponzoni, M.;
- Tripodo, C.;
- Traverse‐Glehen, A.;
- Baseggio, L.;
- Liberati, A.;
- Merli, M.;
- Tessoulin, B.;
- Patti, C.;
- Cabras, M.
Publication type:
Article
ANAPLASTIC LARGE CELL LYMPHOMA, ALK‐NEGATIVE: ANALYSIS OF 235 CASES COLLECTED BY THE T‐CELL PROJECT.
Published in:
Hematological Oncology, 2019, v. 37, p. 283, doi. 10.1002/hon.93_2630
By:
- Shustov, A.;
- Cabrera, M.;
- Bellei, M.;
- Civallero, M.;
- Ko, Y.H.;
- Manni, M.;
- Horwitz, S.M.;
- Antonio De Souza, C.;
- Radford, J.;
- Varela, S.B.;
- Prates, M.V.;
- Ferreri, A.;
- Chiattone, C.;
- Spina, M.;
- Vose, J.M.;
- Chiappella, A.;
- Laszlo, D.;
- Marino, D.;
- Stelitano, C.;
- Skrypets, T.
Publication type:
Article
LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT).
Published in:
Hematological Oncology, 2019, v. 37, p. 256, doi. 10.1002/hon.65_2630
By:
- Ferreri, A.J.;
- Sassone, M.C.;
- Angelillo, P.;
- Zaja, F.;
- Re, A.;
- Spina, M.;
- Di Rocco, A.;
- Fabbri, A.;
- Stelitano, C.;
- Frezzato, M.;
- Rusconi, C.;
- Zambello, R.;
- Arcari, A.;
- Bertoldero, G.;
- De Lorenzo, D.;
- Volpetti, S.;
- Calimeri, T.;
- Perrone, S.;
- Cecchetti, C.;
- Ciceri, F.
Publication type:
Article
FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 224, doi. 10.1002/hon.39_2630
By:
- Ferrero, S.;
- Ladetto, M.;
- Beldjord, K.;
- Drandi, D.;
- Stelitano, C.;
- Bernard, S.;
- Castagnari, B.;
- Bouabdallah, K.;
- Cesaretti, M.;
- Alvarez, I.;
- Gressin, R.;
- Ponzoni, M.;
- Tripodo, C.;
- Traverse‐Glehen, A.;
- Baseggio, L.;
- Liberati, A.;
- Merli, M.;
- Tessoulin, B.;
- Patti, C.;
- Cabras, M.
Publication type:
Article
LONG TERM RESULTS OF THE FOLL05 RANDOMIZED STUDY COMPARING R-CVP WITH R-CHOP AND R-FM AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA. A FIL STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 34, doi. 10.1002/hon.2437_14
By:
- Luminari, S.;
- Tarantino, V.;
- Anastasia, A.;
- Boccomini, C.;
- Chiarenza, A.;
- Rigacci, L.;
- Angelucci, E.;
- Ferrari, A.;
- Pulsoni, A.;
- Rattotti, S.;
- Angrilli, F.;
- Gaidano, G.;
- Stelitano, C.;
- Bertoldero, G.;
- Cascavilla, N.;
- Salvi, F.;
- Ferreri, A.J.;
- Vallisa, D.;
- Balzarotti, M.;
- Cox, M.C.
Publication type:
Article
CLINICAL CHARACTERISTICS OF PATIENTS WITH NEGATIVE INTERIM-PET AND POSITIVE FINAL PET: DATA FROM THE PROSPECTIVE PET-ORIENTED HD0801 STUDY BY FONDAZIONE ITALIANA LINFOMI (FIL).
Published in:
Hematological Oncology, 2017, v. 35, p. 38, doi. 10.1002/hon.2437_19
By:
- Rigacci, L.;
- Puccini, B.;
- Zinzani, P.;
- Kovalchuk, S.;
- Broccoli, A.;
- Evangelista, A.;
- Gioia, D.;
- Mannelli, L.;
- Castagnoli, A.;
- Santoro, A.;
- Bonfichi, M.;
- Rossi, G.;
- Anastasia, A.;
- Zaja, F.;
- Vitolo, U.;
- Pavone, V.;
- Pulsoni, A.;
- Gaidano, G.;
- Stelitano, C.;
- Salvi, F.
Publication type:
Article
POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESSING THE OUTCOME OF PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA ENROLLED IN THE FOLL05 TRIAL BY FIL.
Published in:
Hematological Oncology, 2017, v. 35, p. 228, doi. 10.1002/hon.2438_91
By:
- Luminari, S.;
- Marcheselli, L.;
- Manni, M.;
- Anastasia, A.;
- Vitolo, U.;
- Chiarenza, A.;
- Rigacci, L.;
- Angelucci, E.;
- Fama, A.;
- Pulsoni, A.;
- Rattotti, S.;
- Angrilli, F.;
- Gaidano, G.;
- Stelitano, C.;
- Bertoldero, G.;
- Cascavilla, N.;
- Salvi, F.;
- Ferreri, A.J.;
- Tarantino, V.;
- Bellei, M.
Publication type:
Article
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: Phase 2 study of the Italian Lymphoma Foundation.
Published in:
2012
By:
- Ferrario A;
- Pulsoni A;
- Olivero B;
- Rossi G;
- Vitolo U;
- Tedeschi A;
- Merli F;
- Rigacci L;
- Stelitano C;
- Goldaniga M;
- Mannina D;
- Musto P;
- Rossi F;
- Gamba E;
- Baldini L
Publication type:
Journal Article
Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma.
Published in:
2009
By:
- Luminari S;
- Marcheselli L;
- Sacchi S;
- Pozzi S;
- Bari A;
- Ilariucci F;
- Stelitano C;
- Angrilli F;
- Lazzaro A;
- Baldini L
Publication type:
Journal Article
The CX3C Chemokine Fractalkine (CX3CL1) Is Detectable in Serum of B Cell Chronic Lymphocytic Leukemia Patients with Lymph Node Involvement.
Published in:
Acta Haematologica, 2005, v. 113, n. 2, p. 152, doi. 10.1159/000083456
By:
- Morabito, F.;
- Merendino, R. A.;
- Penna, G.;
- Cuzzola, M.;
- Stelitano, C.;
- Callea, V.;
- Di Pasquale, G.;
- Minciullo, P. L.;
- Gangemi, S.
Publication type:
Article
Temozolomide as salvage treatment in primary brain lymphomas.
Published in:
2007
By:
- Reni, M.;
- Zaja, F.;
- Mason, W.;
- Perry, J.;
- Mazza, E.;
- Spina, M.;
- Bordonaro, R.;
- Ilariucci, F.;
- Faedi, M.;
- Corazzelli, G.;
- Manno, P.;
- Franceschi, E.;
- Pace, A.;
- Candela, M.;
- Abbadessa, A.;
- Stelitano, C.;
- Latte, G.;
- Ferreri, A. J. M.
Publication type:
journal article

Found: 24